Esperion Reports Second Quarter 2024 Financial Results, Provides Business Update

Posted on August 12, 2024 by Vaseline

Esperion Reports Second Quarter 2024 Financial Results, Provides Business Update

– Total revenue increased 186% year-over-year to $73.8 million with
US net product sales of $28.3 million, representing 39% growth –

– Total retail prescription equivalents increased 14% Q1, with an increase of ~11% during the last four weeks of Q2 –